文献速递血栓与止血

2014至2019年英国急性血栓性血小板减少性紫癜及时管理中诊断不确定性构成障碍

Diagnostic uncertainty presented barriers to the timely management of acute thrombotic thrombocytopenic purpura in the United Kingdom between 2014 and 2019.
PubMed 文献 · J Thromb Haemost · 2022-03-11

HaemSTAR对2014至2019年英国80家医院148例首发急性TTP成人进行回顾性全国调查,64.8%在24小时内接受血浆置换;诊断不确定性是延迟治疗最常见原因,接受血浆置换者死亡率为9.2%,其中27.8%的死亡与延迟治疗相关。

要点

  • 148例中64.8%在24小时内接受血浆置换,诊断不确定性是最常见延迟原因。
  • 首次全血细胞计数发现红细胞碎片或重度血小板减少者接受血浆置换时间更短。
  • 接受血浆置换者死亡率9.2%,27.8%的死亡与延迟治疗相关。

核心结论

  • 这是首个急性TTP治疗延迟的多中心评估,将为改进及时获得挽救性干预的靶向路径提供信息。

研究设计与样本

  • HaemSTAR培训研究网络开展回顾性全国性综述,纳入2014至2019年英国80家医院治疗的148例首发急性TTP成人患者。

主要发现

  • 148例患者中64.8%在24小时内接受血浆置换。
  • 诊断不确定性是延迟治疗最常被提及的原因。
  • 首次全血细胞计数发现红细胞碎片或重度血小板减少的患者接受血浆置换时间更短。
  • 具备现场血浆置换条件与转诊患者相比,接受8小时内血浆置换的患者比例更高,但24小时时两组无差异且三分之二患者已接受首次血浆置换。
  • 接受血浆置换的患者死亡率为9.2%,其中27.8%的死亡与延迟治疗启动相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute thrombotic thrombocytopenic purpura (TTP) is a life-threatening emergency and plasma exchange (PEX) is the initial treatment shown to reduce acute mortality. OBJECTIVES: To compare current practice in the United Kingdom (UK) against the standards set out in the 2012 British Society of Haematology guideline, and to better understand the issues affecting prompt initiation of PEX. PATIENTS/METHODS: The trainee research network HaemSTAR conducted a retrospective nationwide review of adults presenting to UK hospitals with a first episode of acute TTP. RESULTS: Data on 148 patients treated at 80 UK hospitals between 2014 and 2019 demonstrated that 64.8% of patients received PEX within 24 h. Diagnostic uncertainty was the most commonly cited reason for delayed treatment. Conversely, a shorter time to PEX occurred in patients who had red cell fragments or severe thrombocytopenia identified on their first complete blood count. Availability of on-site PEX was associated with a greater proportion of patients receiving PEX within 8 h compared to patients transferred, but by 24 h there was no difference between the two groups and two-thirds of all patients had received their first PEX. The mortality rate for patients that received PEX was 9.2%, with 27.8% of deaths linked to delayed treatment initiation. CONCLUSIONS: This is the first multi-center evaluation of treatment delays in acute TTP and it will inform targeted pathways to improve prompt access to life-saving intervention.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Diagnostic uncertainty presented barriers to the timely management of acute thrombotic thrombocytopenic purpura in the United Kingdom between 2014 and 2019. J Thromb Haemost. 2022. PMID: 35189012. doi:10.1111/jth.15681

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。